FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Xuemei Wang

Research Profile

Concepts & Ideas

Procedures

Disorders

Chemicals & Drugs

Physiology

Disease Progression

Co-author Network

Publications

TOP 3
Muslim Atiq; Manoop S Bhutani; Yun Gong; Milind Javle; Gottumukkala S Raju; William A Ross; Eric P Tamm; Xuemei Wang; Jeffrey H Lee
Role of endoscopic ultrasonography in evaluation of metastatic lesions to the pancreas: a tertiary cancer center experience.
Daniela Hoehn; Hagop M Kantarjian; L Jeffrey Medeiros; Xuemei Wang; Jorge E Cortes; Carlos E Bueso-Ramos
Digital image analysis as a tool to assess the effects of imatinib on trabecular bone in patients with chronic myelogenous leukemia.
Stefan Faderl; Jennie Feliu; Alessandra Ferrajoli; Guillermo Garcia-Manero; Xuelin Huang; Elias Jabbour; Tapan Kadia; Gautam Borthakur; Jan Burger; Marina Konopleva; Farhad Ravandi; Xuemei Wang; Hagop M Kantarjian
Clofarabine plus low-dose cytarabine followed by clofarabine plus low-dose cytarabine alternating with decitabine in acute myeloid leukemia frontline therapy for older patients.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Xuemei Wang (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Muslim Atiq; Manoop S Bhutani; Yun Gong; Milind Javle; Gottumukkala S Raju; William A Ross; Eric P Tamm; Xuemei Wang; Jeffrey H Lee
Role of endoscopic ultrasonography in evaluation of metastatic lesions to the pancreas: a tertiary cancer center experience.
Pancreas 2013;42(3):516-23.
2012: Daniela Hoehn; Hagop M Kantarjian; L Jeffrey Medeiros; Xuemei Wang; Jorge E Cortes; Carlos E Bueso-Ramos
Digital image analysis as a tool to assess the effects of imatinib on trabecular bone in patients with chronic myelogenous leukemia.
Human pathology 2012;43(12):2354-9.
2012: Stefan Faderl; Jennie Feliu; Alessandra Ferrajoli; Guillermo Garcia-Manero; Xuelin Huang; Elias Jabbour; Tapan Kadia; Gautam Borthakur; Jan Burger; Marina Konopleva; Farhad Ravandi; Xuemei Wang; Hagop M Kantarjian
Clofarabine plus low-dose cytarabine followed by clofarabine plus low-dose cytarabine alternating with decitabine in acute myeloid leukemia frontline therapy for older patients.
Cancer 2012;118(18):4471-7.
2012: Ching-Wei D Tzeng; Gauri Varadhachary; Jean-Nicolas Vauthey; Xuemei Wang; Robert A Wolff; Jason B Fleming; Jeffrey E Lee; Peter W T Pisters; Matthew H G Katz
Yield of clinical and radiographic surveillance in patients with resected pancreatic adenocarcinoma following multimodal therapy.
HPB : the official journal of the International Hepato Pancreato Biliary Association 2012;14(6):365-72.
2012: Farhad Ravandi; Xuemei Wang; Michael Andreeff; Mark Brandt; Jorge Cortes; Stefan Faderl; Guillermo Garcia-Manero; Tapan Kadia; Marina Konopleva; Steven Kornblau; Rajyalakshmi Luthra; Keyur Patel; Sherry Pierce; Hagop Kantarjian
Prognostic significance of alterations in IDH enzyme isoforms in patients with AML treated with high-dose cytarabine and idarubicin.
Cancer 2012;118(10):2665-73.
2012: Muslim Atiq; Mehmet Bektas; Manoop S Bhutani; Yun Gong; Jeffrey E Lee; Gottumukkala S Raju; William A Ross; Chintan P Shah; Eric P Tamm; Xuemei Wang; James Yao; Jeffrey H Lee
EUS-FNA for pancreatic neuroendocrine tumors: a tertiary cancer center experience.
Digestive diseases and sciences 2012;57(3):791-800.
2012: Ignacio Garrido-Laguna; David S Hong; Filip Janku; Rajyalakshmi Luthra; Aung Naing; Ly M Nguyen; Xuemei Wang; Jenifer J Wheler; Gerald S Falchook; Siqing Fu; Razelle Kurzrock
KRASness and PIK3CAness in patients with advanced colorectal cancer: outcome after treatment with early-phase trials with targeted pathway inhibitors.
PloS one 2012;7(5):e38033.
2011: Stefan O Ciurea; Marcos De Lima; Fleur Aung; Pedro Cano; Richard E Champlin; Ying Hu; Martin Korbling; Jeffrey J Molldrem; Gabriela Rondon; Elizabeth J Shpall; Peter F Thall; Sa A Wang; Xuemei Wang; Marcelo Fernandez-Vina
Donor-specific anti-HLA Abs and graft failure in matched unrelated donor hematopoietic stem cell transplantation.
Blood 2011;118(22):5957-64.
2011: Min S Park; Shreyaskumar R Patel; Jonathan Trent; Wei-Lien Wang; Xuemei Wang; Robert S Benjamin; Piyaporn Boonsirikamchai; Haesun Choi; Charles A Conrad; Alexander J Lazar; Joseph A Ludwig; Dejka M Araujo
Activity of temozolomide and bevacizumab in the treatment of locally advanced, recurrent, and metastatic hemangiopericytoma and malignant solitary fibrous tumor.
Cancer 2011;117(21):4939-47.
2011: Gheath Alatrash; Richard E Champlin; Alexandre Chiattone; Marcos De Lima; Leandro de Padua Silva; Sergio A Giralt; Nelson Hamerschlak; Chitra Hosing; Partow Kebriaei; Fabio Kerbauy; Yago Nieto; Matteo Pelosini; Muzaffar H Qazilbash; Gabriela Rondon; Rima M Saliba; Xuemei Wang; Lianchun Xiao; Weiqing Zhang; Borje S Andersson
Myeloablative reduced-toxicity i.v. busulfan-fludarabine and allogeneic hematopoietic stem cell transplant for patients with acute myeloid leukemia or myelodysplastic syndrome in the sixth through eighth decades of life.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2011;17(10):1490-6.
2011: James M Reuben; Xuemei Wang; Evan N Cohen; Massimo Cristofanilli; Hui Gao; Antonio Giordano; Gabriel N Hortobagyi; Savitri Krishnamurthy; Bang-Ning Lee; Ashutosh Lodhi; Anthony Lucci; Michel Mego; Wendy A Woodward
Primary breast cancer patients with high risk clinicopathologic features have high percentages of bone marrow epithelial cells with ALDH activity and CD44⁺CD24lo cancer stem cell phenotype.
European journal of cancer (Oxford, England : 1990) 2011;47(10):1527-36.
2011: Borje S Andersson; Benigno C Valdez; Marcos De Lima; Xuemei Wang; Peter F Thall; Laura L Worth; Uday Popat; Timothy Madden; Chitra Hosing; Amin Alousi; Gabriela Rondon; Partow Kebriaei; Elizabeth J Shpall; Roy B Jones; Richard E Champlin
Clofarabine ± fludarabine with once daily i.v. busulfan as pretransplant conditioning therapy for advanced myeloid leukemia and MDS.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2011;17(6):893-900.
2011: Filip Janku; Apostolia-Maria Tsimberidou; Ignacio Garrido-Laguna; Xuemei Wang; Rajyalakshmi Luthra; David S Hong; Aung Naing; Gerald S Falchook; John W Moroney; Sarina A Piha-Paul; Jennifer J Wheler; Stacy L Moulder; Siqing Fu; Razelle Kurzrock
PIK3CA mutations in patients with advanced cancers treated with PI3K/AKT/mTOR axis inhibitors.
Molecular cancer therapeutics 2011;10(3):558-65.
2011: Jianlan Sun; Sergej Konoplev; Xuemei Wang; Wei Cui; Su S Chen; L Jeffrey Medeiros; Pei Lin
De novo acute myeloid leukemia with inv(3)(q21q26.2) or t(3;3)(q21;q26.2): a clinicopathologic and cytogenetic study of an entity recently added to the WHO classification.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2011;24(3):384-9.
2011: Partow Kebriaei; Timothy Madden; Reza Kazerooni; Xuemei Wang; Peter F Thall; Celina Ledesma; Yago Nieto; Elizabeth J Shpall; Chitra Hosing; Muzaffar H Qazilbash; Uday Popat; Issa Khouri; Richard E Champlin; Roy B Jones; Borje S Andersson
Intravenous busulfan plus melphalan is a highly effective, well-tolerated preparative regimen for autologous stem cell transplantation in patients with advanced lymphoid malignancies.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2011;17(3):412-20.
2011: Filip Janku; Apostolia-Maria Tsimberidou; Xuemei Wang; David S Hong; Aung Naing; Jing Gong; Ignacio Garrido-Laguna; Henrique A Parsons; Ralph G Zinner; Razelle Kurzrock
Outcomes of patients with advanced non-small cell lung cancer treated in a phase I clinic.
The oncologist 2011;16(3):327-35.
2010: Srikrishna V Patnana; Santosh Murthy; Lianchun Xiao; Eric M Rohren; Wayne L Hofstetter; Stephen G Swisher; Zhongxing Liao; Jeffrey H Lee; Manoop S Bhutani; Homer A Macapinlac; Xuemei Wang; Jaffer A Ajani
Critical role of surgery in patients with gastroesophageal carcinoma with a poor prognosis after chemoradiation as defined by positron emission tomography.
Cancer 2010;116(19):4487-94.
2010: Sergej Konoplev; Herbert A Fritsche; Susan O'Brien; William G Wierda; Michael J Keating; Terrie G Gornet; Susan St Romain; Xuemei Wang; Kedar Inamdar; Malisha R Johnson; L Jeffrey Medeiros; Carlos E Bueso-Ramos
High serum thymidine kinase 1 level predicts poorer survival in patients with chronic lymphocytic leukemia.
American journal of clinical pathology 2010;134(3):472-7.
2010: Ignacio Garrido-Laguna; Filip Janku; Gerald S Falchook; Siqing Fu; David S Hong; Aung Naing; Joanne Aaron; Xuemei Wang; Merrill Kies; Razelle Kurzrock
Patients with advanced head and neck cancers have similar progression-free survival on phase I trials and their last food and drug administration-approved treatment.
Clinical cancer research : an official journal of the American Association for Cancer Research 2010;16(15):4031-7.
2010: Milena S Nicoloso; Hao Sun; Riccardo Spizzo; Hyunsoo Kim; Priyankara Wickramasinghe; Masayoshi Shimizu; Sylwia E Wojcik; Jana Ferdin; Tanja Kunej; Lianchun Xiao; Siranoush Manoukian; Giorgio Secreto; Fernando Ravagnani; Xuemei Wang; Paolo Radice; Carlo M Croce; Ramana V Davuluri; George A Calin
Single-nucleotide polymorphisms inside microRNA target sites influence tumor susceptibility.
Cancer research 2010;70(7):2789-98.
2010: Jaffer A Ajani; Xuemei Wang; Julie G Izzo; Christopher H Crane; Cathy Eng; John M Skibber; Prajnan Das; Asif Rashid
Molecular biomarkers correlate with disease-free survival in patients with anal canal carcinoma treated with chemoradiation.
Digestive diseases and sciences 2010;55(4):1098-105.
2010: Gheath Alatrash; Maher Albitar; Susan O'Brien; Xuemei Wang; Taghi Manshouri; Stefan Faderl; Alessandra Ferrajoli; Jan Burger; Guillermo Garcia-Manero; Hagop M Kantarjian; Susan Lerner; Michael J Keating; Jan A Burger
Circulating CD52 and CD20 levels at end of treatment predict for progression and survival in patients with chronic lymphocytic leukaemia treated with fludarabine, cyclophosphamide and rituximab (FCR).
British journal of haematology 2010;148(3):386-93.
2010: Jamie F Shapiro; Judy L Chase; Robert A Wolff; Laura A Lambert; Paul F Mansfield; Michael J Overman; Aki Ohinata; Jun Liu; Xuemei Wang; Cathy Eng
Modern systemic chemotherapy in surgically unresectable neoplasms of appendiceal origin: a single-institution experience.
Cancer 2010;116(2):316-22.
2010: Saroj Vadhan-Raj; Xiao Zhou; Kurt Sizer; Lincy Lal; Xuemei Wang; Joyce Roquemore; Weiming Shi; Robert S Benjamin; Benjamin Lichtiger
Impact of safety concerns and regulatory changes on the usage of erythropoiesis-stimulating agents and RBC transfusions.
The oncologist 2010;15(12):1359-69.
2010: Santosh Murthy; Srikrishna V Patnana; Lianchun Xiao; Eric M Rohren; Wayne L Hofstetter; Stephen G Swisher; Zhongxing Liao; Jeffrey H Lee; Manoop S Bhutani; Homer A Macapinlac; Xuemei Wang; Jaffer A Ajani
The standardized uptake value of 18-fluorodeoxyglucose positron emission tomography after chemoradiation and clinical outcome in patients with localized gastroesophageal carcinoma.
Oncology 2010;78(5-6):316-22.
2009: Heta Javeri; Lianchun Xiao; Eric M Rohren; Jeffrey H Lee; Zhongxing Liao; Wayne L Hofstetter; Dipen Maru; Manoop S Bhutani; Stephen G Swisher; Homer A Macapinlac; Xuemei Wang; Jaffer A Ajani
The higher the decrease in the standardized uptake value of positron emission tomography after chemoradiation, the better the survival of patients with gastroesophageal adenocarcinoma.
Cancer 2009;115(22):5184-92.
2009: Paul Armistead; Marcos De Lima; Sherry Pierce; Wei Qiao; Xuemei Wang; Peter F Thall; Sergio Giralt; Farhad Ravandi; Andrew Lamb; Richard Champlin; Elihu Estey
Quantifying the survival benefit for allogeneic hematopoietic stem cell transplantation in relapsed acute myelogenous leukemia.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2009;15(11):1431-8.
2009: Stefan O Ciurea; Marcos De Lima; Pedro Cano; Martin Korbling; Sergio Giralt; Elizabeth J Shpall; Xuemei Wang; Peter F Thall; Richard E Champlin; Marcelo Fernandez-Vina
High risk of graft failure in patients with anti-HLA antibodies undergoing haploidentical stem-cell transplantation.
Transplantation 2009;88(8):1019-24.
2009: Eric Jonasch; Christopher G Wood; Surena F Matin; Shi-Ming Tu; Lance C Pagliaro; Paul G Corn; Ana Aparicio; Pheroze Tamboli; Randall E Millikan; Xuemei Wang; John C Araujo; Wadih Arap; Nizar M Tannir
Phase II presurgical feasibility study of bevacizumab in untreated patients with metastatic renal cell carcinoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(25):4076-81.
2009: Guy Lahat; Alexander Lazar; Xuemei Wang; Wei-Lien Wang; Quan-Sheng Zhu; Kelly K Hunt; Raphael E Pollock; Dina lev
Increased vascular endothelial growth factor-C expression is insufficient to induce lymphatic metastasis in human soft-tissue sarcomas.
Clinical cancer research : an official journal of the American Association for Cancer Research 2009;15(8):2637-46.
2009: Jami Mandelin; Emme C K Lin; Dana D Hu; Susan K Knowles; Kim-Anh Do; Xuemei Wang; E Helene Sage; Jeffrey W Smith; Wadih Arap; Renata Pasqualini
Extracellular and intracellular mechanisms that mediate the metastatic activity of exogenous osteopontin.
Cancer 2009;115(8):1753-64.
2009: Ana Aparicio; Brittany North; Lindsey Barske; Xuemei Wang; Valentina Bollati; Daniel Weisenberger; Christine Yoo; Nizar M Tannir; Erin Horne; Susan Groshen; Peter Jones; Allen Yang; Jean-Pierre J Issa
LINE-1 methylation in plasma DNA as a biomarker of activity of DNA methylation inhibitors in patients with solid tumors.
Epigenetics : official journal of the DNA Methylation Society 2009;4(3):176-84.
2009: Jan A Burger; Susan O'Brien; Xuemei Wang; Stefan Faderl; Alessandra Ferrajoli; Kim-Anh Do; Guillermo Garcia-Manero; Jorge Cortes; Deborah Thomas; Charles Koller; Jan Burger; Susan Lerner; Andrew Lamb; Michael Keating
Characteristics associated with important clinical end points in patients with chronic lymphocytic leukemia at initial treatment.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(10):1637-43.
2009: Dimitra Tsavachidou; Timothy J McDonnell; Sijin Wen; Xuemei Wang; Funda Vakar-Lopez; Louis L Pisters; Curtis A Pettaway; Christopher G Wood; Kim-Anh Do; Peter F Thall; Clifton Stephens; Eleni Efstathiou; Robert Taylor; David G Menter; Patricia Troncoso; Scott M Lippman; Christopher J Logothetis; Jeri Kim
Selenium and vitamin E: cell type- and intervention-specific tissue effects in prostate cancer.
Journal of the National Cancer Institute 2009;101(5):306-20.
2009: Daniel A Anaya; Guy Lahat; Xuemei Wang; Lianchun Xiao; Daniel Tuvin; Peter W Pisters; Dina C Lev; Raphael E Pollock
Establishing prognosis in retroperitoneal sarcoma: a new histology-based paradigm.
Annals of surgical oncology 2009;16(3):667-75.
2009: Heta Javeri; Lianchun Xiao; Eric Rohren; Ritsuko Komaki; Wayne L Hofstetter; Jeffrey H Lee; Dipen Maru; Manoop S Bhutani; Stephen G Swisher; Xuemei Wang; Jaffer A Ajani
Influence of the baseline 18F-fluoro-2-deoxy-D-glucose positron emission tomography results on survival and pathologic response in patients with gastroesophageal cancer undergoing chemoradiation.
Cancer 2009;115(3):624-30.
2008: Gautam Borthakur; Andrew Lamb; Xuemei Wang; William Plunkett; Varsha Gandhi; Stefan Faderl; Guillermo Garcia-Manero; Farhad Ravandi; Sherry Pierce; Elihu H Estey
Treatment of core-binding-factor in acute myelogenous leukemia with fludarabine, cytarabine, and granulocyte colony-stimulating factor results in improved event-free survival.
Cancer 2008;113(11):3181-5.
2008: Kedar V Inamdar; Susan O'Brien; Subrata Sen; Michael Keating; Martin H Nguyen; Xuemei Wang; Michael Fernandez; Vilmos A Thomazy; L Jeffrey Medeiros; Carlos E Bueso-Ramos
Aurora-A kinase nuclear expression in chronic lymphocytic leukemia.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2008;21(12):1428-35.
2008: Curtis A Pettaway; Renduo Song; Xuemei Wang; Ricardo Sanchez-Ortiz; Philippe E Spiess; Sara Strom; Patricia Troncoso
The ratio of matrix metalloproteinase to E-cadherin expression: a pilot study to assess mRNA and protein expression among African American prostate cancer patients.
The Prostate 2008;68(13):1467-76.
2008: Nizar M Tannir; Peter F Thall; Chaan S Ng; Xuemei Wang; Leiko Wooten; Arlene Siefker-Radtke; Paul Mathew; Lance Pagliaro; Christopher Wood; Eric Jonasch
A phase II trial of gemcitabine plus capecitabine for metastatic renal cell cancer previously treated with immunotherapy and targeted agents.
The Journal of urology 2008;180(3):867-72; discussion 872.
2008: Zeming Jin; Guy Lahat; Borys Korchin; Theresa Nguyen; Quan-Sheng Zhu; Xuemei Wang; Alexander Lazar; Jonathan Trent; Raphael E Pollock; Dina lev
Midkine enhances soft-tissue sarcoma growth: a possible novel therapeutic target.
Clinical cancer research : an official journal of the American Association for Cancer Research 2008;14(16):5033-42.
2008: Pei Lin; Lei Chen; Rajyalakshmi Luthra; Sergej Konoplev; Xuemei Wang; L Jeffrey Medeiros
Acute myeloid leukemia harboring t(8;21)(q22;q22): a heterogeneous disease with poor outcome in a subset of patients unrelated to secondary cytogenetic aberrations.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2008;21(8):1029-36.
2008: Borje S Andersson; Marcos De Lima; Peter F Thall; Xuemei Wang; Daniel Couriel; Martin Korbling; Soonja Roberson; Sergio Giralt; Betty Pierre; James A Russell; Elizabeth J Shpall; Roy B Jones; Richard E Champlin
Once daily i.v. busulfan and fludarabine (i.v. Bu-Flu) compares favorably with i.v. busulfan and cyclophosphamide (i.v. BuCy2) as pretransplant conditioning therapy in AML/MDS.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2008;14(6):672-84.
2008: Brian R Weston; William A Ross; Robert A Wolff; Douglas Evans; Jeffrey E Lee; Xuemei Wang; Lian-Chun Xiao; Jeffrey H Lee
Rate of bilirubin regression after stenting in malignant biliary obstruction for the initiation of chemotherapy: how soon should we repeat endoscopic retrograde cholangiopancreatography?
Cancer 2008;112(11):2417-23.
2008: G Lahat; D A Anaya; Xuemei Wang; D Tuvin; Dina lev; Raphael E Pollock
Resectable well-differentiated versus dedifferentiated liposarcomas: two different diseases possibly requiring different treatment approaches.
Annals of surgical oncology 2008;15(6):1585-93.
2008: Michael J Gray; George van Buren; Nikolaos A Dallas; Ling Xia; Xuemei Wang; Anthony D Yang; Ray Somcio; Yvonne G Lin; Sherry Lim; Fan Fan; Lingegowda S Mangala; Thiruvengadam Arumugam; Craig D Logsdon; Gabriel Lopez-Berestein; Anil K Sood; Lee M Ellis
Therapeutic targeting of neuropilin-2 on colorectal carcinoma cells implanted in the murine liver.
Journal of the National Cancer Institute 2008;100(2):109-20.
2008: Toshio Kuwai; Toru Nakamura; Takamitsu Sasaki; Yasuhiko Kitadai; Jang-Seong Kim; Robert R Langley; Dominic Fan; Xuemei Wang; Kim-Anh Do; Sun-Jin Kim; Isaiah J Fidler
Targeting the EGFR, VEGFR, and PDGFR on colon cancer cells and stromal cells is required for therapy.
Clinical & experimental metastasis 2008;25(4):477-89.
2008: Timothy J McDonnell; Nikhil S Chari; Jeong Hee Cho-Vega; Patricia Troncoso; Xuemei Wang; Carlos E Bueso-Ramos; Kevin R Coombes; Shawn Brisbay; Remigio Lopez; George Prendergast; Christopher Logothetis; Kim-Anh Do
Biomarker expression patterns that correlate with high grade features in treatment naive, organ-confined prostate cancer.
BMC medical genomics 2008;1():1.
2007: Hiroyuki Nakanishi; Xuemei Wang; Atsushi Ochiai; Kiril Trpkov; Asli Yilmaz; J Bryan Donnelly; John W Davis; Patricia Troncoso; R Joseph Babaian
A nomogram for predicting low-volume/low-grade prostate cancer: a tool in selecting patients for active surveillance.
Cancer 2007;110(11):2441-7.
2007: Sangjun Lee; Nikhil S Chari; Hyung Woo Kim; Xuemei Wang; Dennis R Roop; Song H Cho; John DiGiovanni; Timothy J McDonnell
Cooperation of Ha-ras and Bcl-2 during multistep skin carcinogenesis.
Molecular carcinogenesis 2007;46(12):949-57.
2007: Shifeng Mao; Danai D Daliani; Xuemei Wang; Peter F Thall; Kim-Anh Do; Cherie A Perez; Melissa A Brown; Kathleen Bouchillon; Cindy M Carter; Christopher J Logothetis; Jeri Kim
Employing the treatment-free interval of intermittent androgen ablation to screen candidate prostate cancer therapies.
The Prostate 2007;67(15):1677-85.
2007: Philippe E Spiess; Curtis A Pettaway; Funda Vakar-Lopez; Wassim Kassouf; Xuemei Wang; J Erik Busby; Kim-Anh Do; Rajayogesh Davuluri; Nizar M Tannir
Treatment outcomes of small cell carcinoma of the prostate: a single-center study.
Cancer 2007;110(8):1729-37.
2007: Melanie Thomas; Romil Chadha; Katrina Glover; Xuemei Wang; Jeffrey Morris; Thomas Brown; Asif Rashid; Janet Dancey; James L Abbruzzese
Phase 2 study of erlotinib in patients with unresectable hepatocellular carcinoma.
Cancer 2007;110(5):1059-67.
2007: Elizabeth A Mittendorf; Xuemei Wang; Nancy D Perrier; Ashleigh M Francis; Beth S Edeiken; Suzanne E Shapiro; Jeffrey E Lee; Douglas B Evans
Followup of patients with papillary thyroid cancer: in search of the optimal algorithm.
Journal of the American College of Surgeons 2007;205(2):239-47.
2007: Peter C Black; Karen Basen-Engquist; Xuemei Wang; Richard J Swartz; Teresa Eddings; Surena F Matin; David Swanson; Christopher G Wood; Louis L Pisters; R Joseph Babaian; Patricia Troncoso; Curtis A Pettaway
A randomized prospective trial evaluating testosterone, haemoglobin kinetics and quality of life, during and after 12 months of androgen deprivation after prostatectomy: results from the Postoperative Adjuvant Androgen Deprivation trial.
BJU international 2007;100(1):63-9.
2007: William G Wierda; Susan O'Brien; Xuemei Wang; Stefan Faderl; Alessandra Ferrajoli; Kim-Anh Do; Jorge Cortes; Deborah Thomas; Guillermo Garcia-Manero; Charles Koller; Miloslav Beran; Francis Giles; Farhad Ravandi; Susan Lerner; Andrew Lamb; Michael Keating
Prognostic nomogram and index for overall survival in previously untreated patients with chronic lymphocytic leukemia.
Blood 2007;109(11):4679-85.
2006: J Erik Busby; Sun-Jin Kim; Sertac Yazici; Toru Nakamura; Jang-Seong Kim; Junqin He; Marva Maya; Xuemei Wang; Kim-Anh Do; Dominic Fan; Isaiah J Fidler
Therapy of multidrug resistant human prostate tumors in the prostate of nude mice by simultaneous targeting of the epidermal growth factor receptor and vascular endothelial growth factor receptor on tumor-associated endothelial cells.
The Prostate 2006;66(16):1788-98.
2006: Nizar M Tannir; Lorenzo Cohen; Xuemei Wang; Peter F Thall; Paul F Mathew; Eric Jonasch; Arlene Siefker-Radtke; Lance C Pagliaro; Chaan S Ng; Christopher Logothetis
Improved tolerability and quality of life with maintained efficacy using twice-daily low-dose interferon-alpha-2b: results of a randomized phase II trial of low-dose versus intermediate-dose interferon-alpha-2b in patients with metastatic renal cell carcinoma.
Cancer 2006;107(9):2254-61.
2006: Philippe E Spiess; Andrew K Lee; Dan Leibovici; Xuemei Wang; Kim-Anh Do; Louis L Pisters
Presalvage prostate-specific antigen (PSA) and PSA doubling time as predictors of biochemical failure of salvage cryotherapy in patients with locally recurrent prostate cancer after radiotherapy.
Cancer 2006;107(2):275-80.
2006: Mihai Merzianu; Liuyan Jiang; Pei Lin; Xuemei Wang; Donna M Weber; Saroj Vadhan-Raj; Martin H Nguyen; L Jeffrey Medeiros; Carlos E Bueso-Ramos
Nuclear BCL-10 expression is common in lymphoplasmacytic lymphoma/Waldenström macroglobulinemia and does not correlate with p65 NF-kappaB activation.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2006;19(7):891-8.
2006: Sun-Jin Kim; Hisanori Uehara; Sertac Yazici; J Erik Busby; Toru Nakamura; Junqin He; Marva Maya; Christopher Logothetis; Paul Mathew; Xuemei Wang; Kim-Anh Do; Dominic Fan; Isaiah J Fidler
Targeting platelet-derived growth factor receptor on endothelial cells of multidrug-resistant prostate cancer.
Journal of the National Cancer Institute 2006;98(11):783-93.
2006: Charles J Rosser; Ashish M Kamat; Xuemei Wang; Kim-Anh Do; Yoshio Naya; David C Hoover; Patricia Troncoso; Ricardo F Sanches-Ortiz; Louis L Pisters
Biochemical disease-free survival in men younger than 60 years with prostate cancer treated with radical prostatectomy.
Urology 2006;67(4):769-73.
2006: Dejka M Steinert; Mauricio P Oyarzo; Xuemei Wang; Haesun Choi; Peter F Thall; L Jeffrey Medeiros; A Kevin Raymond; Robert S Benjamin; Wei Zhang; Jonathan Trent
Expression of Bcl-2 in gastrointestinal stromal tumors: correlation with progression-free survival in 81 patients treated with imatinib mesylate.
Cancer 2006;106(7):1617-23.
2006: Philippe E Spiess; Wassim Kassouf; Gordon Brown; Ralph A Highshaw; Xuemei Wang; Kim-Anh Do; Ashish M Kamat; Bogdan Czerniak; Colin P N Dinney; H Barton Grossman
Immediate versus staged urethrectomy in patients at high risk of urethral recurrence: is there a benefit to either approach?
Urology 2006;67(3):466-71.
2006: William G Wierda; Susan O'Brien; Stefan Faderl; Alessandra Ferrajoli; Xuemei Wang; Kim-Anh Do; Guillermo Garcia-Manero; Deborah Thomas; Jorge Cortes; Farhad Ravandi-Kashani; Francis Giles; Susan Lerner; Andrew Lamb; Michael Keating
A retrospective comparison of three sequential groups of patients with Recurrent/Refractory chronic lymphocytic leukemia treated with fludarabine-based regimens.
Cancer 2006;106(2):337-45.
2005: Sara S Strom; Xuemei Wang; Curtis A Pettaway; Christopher J Logothetis; Yuko Yamamura; Kim-Anh Do; R Joseph Babaian; Patricia Troncoso
Obesity, weight gain, and risk of biochemical failure among prostate cancer patients following prostatectomy.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(19 Pt 1):6889-94.
2005: Charles J Rosser; Ashish M Kamat; Xuemei Wang; Kim-Anh Do; Ricardo F Sanchez-Ortiz; Deborah A Kuban; Andrew K Lee; Rex Cheung; Ramsey Chichakli; Louis L Pisters
Is patient age a factor in the occurrence of prostate-specific antigen bounce phenomenon after external beam radiotherapy for prostate cancer?
Urology 2005;66(2):327-31.
2005: Jeong Hee Cho-Vega; Patricia Troncoso; Kim-Anh Do; Carlo Rago; Xuemei Wang; Spiridon Tsavachidis; L Jeffrey Medeiros; Kevin B Spurgers; Christopher Logothetis; Timothy J McDonnell
Combined laser capture microdissection and serial analysis of gene expression from human tissue samples.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2005;18(4):577-84.
2005: Raymond Wong; Munir Shahjahan; Xuemei Wang; Peter F Thall; Marcos De Lima; Issa Khouri; James L Gajewski; Jorge Alamo; Daniel Couriel; Borje S Andersson; Michele Donato; Chitra Hosing; Krishna Komanduri; Paolo Anderlini; Jeffrey J Molldrem; Naoto T Ueno; Elihu Estey; Cindy Ippoliti; Richard Champlin; Sergio Giralt
Prognostic factors for outcomes of patients with refractory or relapsed acute myelogenous leukemia or myelodysplastic syndromes undergoing allogeneic progenitor cell transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2005;11(2):108-14.
2005: Dan Leibovici; Ashish M Kamat; Kim-Anh Do; Curtis A Pettaway; Chaan S Ng; Robert B Evans; Miguel A Rodriguez-Bigas; John M Skibber; Xuemei Wang; Louis L Pisters
Transrectal ultrasound versus magnetic resonance imaging for detection of rectal wall invasion by prostate cancer.
The Prostate 2005;62(1):101-4.
2004: Janice N Cormier; Xuelin Huang; Yan Xing; Peter F Thall; Xuemei Wang; Robert S Benjamin; Raphael E Pollock; Cristina R Antonescu; ROBERT G MAKI; Murray F Brennan; Peter W T Pisters
Cohort analysis of patients with localized, high-risk, extremity soft tissue sarcoma treated at two cancer centers: chemotherapy-associated outcomes.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2004;22(22):4567-74.
2004: Vasily Assikis; Kim-Anh Do; Sijin Wen; Xuemei Wang; Jeong Hee Cho-Vega; Shawn Brisbay; Remigio Lopez; Christopher J Logothetis; Patricia Troncoso; Christos N Papandreou; Timothy J McDonnell
Clinical and biomarker correlates of androgen-independent, locally aggressive prostate cancer with limited metastatic potential.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(20):6770-8.
2004: Marcos De Lima; Daniel Couriel; Peter F Thall; Xuemei Wang; Timothy Madden; Roy Jones; Elizabeth J Shpall; Munir Shahjahan; Betty Pierre; Sergio Giralt; Martin Korbling; James A Russell; Richard E Champlin; Borje S Andersson
Once-daily intravenous busulfan and fludarabine: clinical and pharmacokinetic results of a myeloablative, reduced-toxicity conditioning regimen for allogeneic stem cell transplantation in AML and MDS.
Blood 2004;104(3):857-64.
2004: Christos N Papandreou; Danai D Daliani; Darrell Nix; Hong Yang; Timothy Madden; Xuemei Wang; Christine S Pien; Randall E Millikan; Shi-Ming Tu; Lance Pagliaro; Jeri Kim; Julian Adams; Peter Elliott; Dixie Esseltine; Alexandria Petrusich; Pauline Dieringer; Cherie Perez; Christopher J Logothetis
Phase I trial of the proteasome inhibitor bortezomib in patients with advanced solid tumors with observations in androgen-independent prostate cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2004;22(11):2108-21.
2004: Louis L Pisters; Curtis A Pettaway; Patricia Troncoso; Timothy J McDonnell; L Clifton Stephens; Christopher G Wood; Kim-Anh Do; Shawn Brisbay; Xuemei Wang; Elizabeth A Hossan; Robert B Evans; Cindy Soto; Marc G Jacobson; Karen Parker; James A Merritt; Mitchell S Steiner; Christopher J Logothetis
Evidence that transfer of functional p53 protein results in increased apoptosis in prostate cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(8):2587-93.
2004: Pei Lin; Suyang Hao; L Jeffrey Medeiros; Elihu H Estey; Sherry A Pierce; Xuemei Wang; Armand B. Glassman; Carlos E Bueso-Ramos; Yang O Huh
Expression of CD2 in acute promyelocytic leukemia correlates with short form of PML-RARalpha transcripts and poorer prognosis.
American journal of clinical pathology 2004;121(3):402-7.
2003: Elihu H Estey; Peter F Thall; Xuemei Wang; Srdan Verstovsek; Jorge Cortes; Hagop M Kantarjian
Effect of circulating blasts at time of complete remission on subsequent relapse-free survival time in newly diagnosed AML.
Blood 2003;102(9):3097-9.
2003: Steven J Frank; Kenneth Forster; Craig W Stevens; James D Cox; Ritsuko Komaki; Zhongxing Liao; Susan Tucker; Xuemei Wang; Roy E Steadham; Chris Brooks; George Starkschall
Treatment planning for lung cancer: traditional homogeneous point-dose prescription compared with heterogeneity-corrected dose-volume prescription.
International journal of radiation oncology, biology, physics 2003;56(5):1308-18.
2003: Amr S Soliman; Xuemei Wang; John DiGiovanni; Sanaa Eissa; Magda Morad; Suryanarayana V Vulimiri; Khaled G Mahgoub; Dennis A Johnston; Kim-Anh Do; Ibrahim A Seifeldin; Paolo Boffetta; Melissa L Bondy
Serum organochlorine levels and history of lactation in Egypt.
Environmental research 2003;92(2):110-7.
2003: Taghi Manshouri; Kim-Anh Do; Xuemei Wang; Francis Giles; Susan M O'Brien; Helene Saffer; Deborah Thomas; Iman Jilani; Hagop M Kantarjian; Michael J Keating; Maher Albitar
Circulating CD20 is detectable in the plasma of patients with chronic lymphocytic leukemia and is of prognostic significance.
Blood 2003;101(7):2507-13.
2003: Paul J Mintz; Jeri Kim; Kim-Anh Do; Xuemei Wang; Ralph G Zinner; Massimo Cristofanilli; Marco A Arap; Waun Ki Hong; Patricia Troncoso; Christopher J Logothetis; Renata Pasqualini; Wadih Arap
Fingerprinting the circulating repertoire of antibodies from cancer patients.
Nature biotechnology 2003;21(1):57-63.
2002: Danai D Daliani; Christos N Papandreou; Peter F Thall; Xuemei Wang; Cherie Perez; Rose Oliva; Lance Pagliaro; Robert J Amato
A pilot study of thalidomide in patients with progressive metastatic renal cell carcinoma.
Cancer 2002;95(4):758-65.
2002: Christos N Papandreou; Danai D Daliani; Peter F Thall; Shi-Ming Tu; Xuemei Wang; Adriana Reyes; Patricia Troncoso; Christopher J Logothetis
Results of a phase II study with doxorubicin, etoposide, and cisplatin in patients with fully characterized small-cell carcinoma of the prostate.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2002;20(14):3072-80.
2002: Karim Fizazi; DM Prow; Kim-Anh Do; Xuemei Wang; LD Finn; Jeri Kim; Danai D Daliani; Christos N Papandreou; Shi-Ming Tu; Randall E Millikan; Lance C Pagliaro; Christopher J Logothetis; Robert J Amato
Alternating dose-dense chemotherapy in patients with high volume disseminated non-seminomatous germ cell tumours.
British journal of cancer 2002;86(10):1555-60.
2002: Jean-Nicolas Vauthey; Eddie K Abdalla; Dorota A Doherty; Philippe Gertsch; Marc J Fenstermacher; Evelyne M Loyer; Jan Lerut; Roland Materne; Xuemei Wang; Arthur Encarnacion; Delise Herron; Christian Mathey; Giovanni Ferrari; Chusilp Charnsangavej; Kim-Anh Do; Alban Denys
Body surface area and body weight predict total liver volume in Western adults.
Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 2002;8(3):233-40.
2002: Dory A Sample; Michael J Wargovich; Susan M Fischer; Nikil Inamdar; Peter Schwartz; Xuemei Wang; Kim-Anh Do; Frank A Sinicrope
A dose-finding study of aspirin for chemoprevention utilizing rectal mucosal prostaglandin E(2) levels as a biomarker.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2002;11(3):275-9.
2002: Syed A Ahmad; Shreyaskumar R Patel; Matthew T. Ballo; Treneth P Baker; Alan W Yasko; Xuemei Wang; Barry W Feig; Kelly K Hunt; Patrick P Lin; Kristin L Weber; Lei L Chen; Gunar K Zagars; Raphael E Pollock; Robert S Benjamin; Peter W T Pisters
Extraosseous osteosarcoma: response to treatment and long-term outcome.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2002;20(2):521-7.
2002: Borje S Andersson; Peter F Thall; Timothy Madden; Daniel Couriel; Xuemei Wang; Hai T Tran; Paolo Anderlini; Marcos De Lima; James L Gajewski; Richard E Champlin
Busulfan systemic exposure relative to regimen-related toxicity and acute graft-versus-host disease: defining a therapeutic window for i.v. BuCy2 in chronic myelogenous leukemia.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2002;8(9):477-85.
2002: Karim Fizazi; Kim-Anh Do; Xuemei Wang; LD Finn; Christopher J Logothetis; Robert J Amato
A 20% dose reduction of the original CISCA/VB regimen allows better tolerance and similar survival rate in disseminated testicular non-seminomatous germ-cell tumors: final results of a phase III randomized trial.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2002;13(1):125-34.
2001: Elihu H Estey; Peter F Thall; Jorge E Cortes; Francis Giles; Susan O'Brien; Sherry A Pierce; Xuemei Wang; Hagop M Kantarjian; Miloslav Beran
Comparison of idarubicin + ara-C-, fludarabine + ara-C-, and topotecan + ara-C-based regimens in treatment of newly diagnosed acute myeloid leukemia, refractory anemia with excess blasts in transformation, or refractory anemia with excess blasts.
Blood 2001;98(13):3575-83.
2001: Jennifer E Tseng; Bonnie S Glisson; Fadlo R Khuri; Dong M Shin; Jeffrey N Myers; Adel K El-Naggar; Jennifer S Roach; Lawrence E Ginsberg; Peter F Thall; Xuemei Wang; S Teddy; KN Lawhorn; R E Zentgraf; G D Steinhaus; James Pluda; James L Abbruzzese; Waun Ki Hong; Roy S Herbst
Phase II study of the antiangiogenesis agent thalidomide in recurrent or metastatic squamous cell carcinoma of the head and neck.
Cancer 2001;92(9):2364-73.
2001: Syed A Ahmad; Malcolm M Bilimoria; Xuemei Wang; Francesco Izzo; Paolo Delrio; Paolo Marra; Treneth P Baker; G A Porter; Lee M Ellis; Jean-Nicolas Vauthey; S Dhamotharan; Steven A Curley
Hepatitis B or C virus serology as a prognostic factor in patients with hepatocellular carcinoma.
Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract 2001;5(5):468-76.
2001: Sergio Giralt; Peter F Thall; Issa Khouri; Xuemei Wang; Ira Braunschweig; C Ippolitti; David F Claxton; Michele Donato; Jill Bruton; Agueda Cohen; M Davis; Borje S Andersson; Paolo Anderlini; James L Gajewski; Steven M Kornblau; Michael Andreeff; Donna Przepiorka; Naoto T Ueno; Jeffrey J Molldrem; Richard Champlin
Melphalan and purine analog-containing preparative regimens: reduced-intensity conditioning for patients with hematologic malignancies undergoing allogeneic progenitor cell transplantation.
Blood 2001;97(3):631-7.
1998: Alice J Sigurdson; Melissa L Bondy; Kenneth R Hess; Steven Toms; Athanassios P Kyritsis; Jian Gu; Li-E Wang; Xuemei Wang; Phyllis Adatto; J L Bruner; W K Alfred Yung; Victor Levin; Qingyi Wei
Gamma-ray mutagen sensitivity and survival in patients with glioma.
Clinical cancer research : an official journal of the American Association for Cancer Research 1998;4(12):3031-5.